KZIA Stock Analysis: Buy, Sell, or Hold?
KZIA - Kazia Therapeutics Limited American Depositary Shares
$6.20
0.34 (5.80%)
▲
5d:
-21.82%
30d:
-10.01%
90d:
-19.27%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Feb 06, 2026
3d
Get Alerted When KZIA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KZIA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: KZIA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: KZIA is currently trading at $6.20, which is considered fair relative to its 30-day fair value range of $5.99 to $8.34.
Technical Outlook: Technically, KZIA is showing sideways momentum. Immediate support is located at $5.28, while resistance sits at $8.18. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: KZIA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $18.98 (+223.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KZIA is showing sideways momentum. Immediate support is located at $5.28, while resistance sits at $8.18. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: KZIA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $18.98 (+223.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$5.99 -
$8.34
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.8%)
- BULLISH: Trading 223.8% below Wall St target ($18.98)
- CAUTION: 5-day price weakness (-21.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$5.99 -
$8.34
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$5.28
Resistance Level
$8.18
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-527.93
Wall Street Target
$18.98
(+223.8%)
Revenue Growth (YoY)
-27.2%
Last updated: February 02, 2026 3:36 PM ET
Data refreshes hourly during market hours. Next update: 4:36 PM
Data refreshes hourly during market hours. Next update: 4:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KZIA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 57 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 59 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 64 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
